Recent

• Glassman, P.M. (2024). Development of a predictive algorithm for the efficacy of half-life extension strategies. Int J Pharm, 660, 124382. Netherlands. 10.1016/j.ijpharm.2024.124382

• Glassman, P.M., Villa, C.H., Marcos-Contreras, O.A., Hood, E.D., Walsh, L.R., Greineder, C.F., Myerson, J.W., Shuvaeva, T., Puentes, L., Brenner, J.S., Siegel, D.L., & Muzykantov, V.R. (2022). Targeted In Vivo Loading of Red Blood Cells Markedly Prolongs Nanocarrier Circulation. Bioconjug Chem, 33(7), 1286-1294. United States. 10.1021/acs.bioconjchem.2c00196

• Nong, J., Glassman, P.M., & Muzykantov, V.R. (2022). Targeting vascular inflammation through emerging methods and drug carriers. Adv Drug Deliv Rev, 184, 114180. Netherlands. 10.1016/j.addr.2022.114180

• Wang, Z., Hood, E.D., Nong, J., Ding, J., Marcos-Contreras, O.A., Glassman, P.M., Rubey, K.M., Zaleski, M., Espy, C.L., Gullipali, D., Miwa, T., Muzykantov, V.R., Song, W., Myerson, J.W., & Brenner, J.S. (2022). Combating Complement's Deleterious Effects on Nanomedicine by Conjugating Complement Regulatory Proteins to Nanoparticles. Adv Mater, 34(8), e2107070. Germany. 10.1002/adma.202107070

• Myerson, J.W., Patel, P.N., Rubey, K.M., Zamora, M.E., Zaleski, M.H., Habibi, N., Walsh, L.R., Lee, Y., Luther, D.C., Ferguson, L.T., Marcos-Contreras, O.A., Glassman, P.M., Mazaleuskaya, L.L., Johnston, I., Hood, E.D., Shuvaeva, T., Wu, J., Zhang, H., Gregory, J.V., Kiseleva, R.Y., Nong, J., Grosser, T., Greineder, C.F., Mitragotri, S., Worthen, G.S., Rotello, V.M., Lahann, J., Muzykantov, V.R., & Brenner, J.S. (2022). Supramolecular arrangement of protein in nanoparticle structures predicts nanoparticle tropism for neutrophils in acute lung inflammation. Nat Nanotechnol, 17(1), 86-97. England. 10.1038/s41565-021-00997-y

• Glassman, P.M., Hood, E.D., Ferguson, L.T., Zhao, Z., Siegel, D.L., Mitragotri, S., Brenner, J.S., & Muzykantov, V.R. (2021). Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers. Adv Drug Deliv Rev, 178, 113992. Netherlands. 10.1016/j.addr.2021.113992

• Glassman, P.M. & Muzykantov, V.R. (2020). Target-mediated exposure enhancement: a previously unexplored limit of TMDD. J Pharmacokinet Pharmacodyn, 47(5), 411-420. United States. 10.1007/s10928-020-09693-1

• Glassman, P.M., Villa, C.H., Ukidve, A., Zhao, Z., Smith, P., Mitragotri, S., Russell, A.J., Brenner, J.S., & Muzykantov, V.R. (2020). Vascular Drug Delivery Using Carrier Red Blood Cells: Focus on RBC Surface Loading and Pharmacokinetics. Pharmaceutics, 12(5). Switzerland. 10.3390/pharmaceutics12050440

• Glassman, P.M., Walsh, L.R., Villa, C.H., Marcos-Contreras, O.A., Hood, E.D., Muzykantov, V.R., & Greineder, C.F. (2020). Molecularly Engineered Nanobodies for Tunable Pharmacokinetics and Drug Delivery. Bioconjug Chem, 31(4), 1144-1155. United States. 10.1021/acs.bioconjchem.0c00003

• Marcos-Contreras, O.A., Greineder, C.F., Kiseleva, R.Y., Parhiz, H., Walsh, L.R., Zuluaga-Ramirez, V., Myerson, J.W., Hood, E.D., Villa, C.H., Tombacz, I., Pardi, N., Seliga, A., Mui, B.L., Tam, Y.K., Glassman, P.M., Shuvaev, V.V., Nong, J., Brenner, J.S., Khoshnejad, M., Madden, T., Weissmann, D., Persidsky, Y., & Muzykantov, V.R. (2020). Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood-brain barrier. Proc Natl Acad Sci U S A, 117(7), 3405-3414. United States. 10.1073/pnas.1912012117

• Glassman, P.M., Myerson, J.W., Ferguson, L.T., Kiseleva, R.Y., Shuvaev, V.V., Brenner, J.S., & Muzykantov, V.R. (2020). Targeting drug delivery in the vascular system: Focus on endothelium. Adv Drug Deliv Rev, 157, 96-117. Netherlands. 10.1016/j.addr.2020.06.013